{"id":"W4406869106","doi":"10.1200/jco.2025.43.4_suppl.602","title":"Pembrolizumab and stereotactic radiotherapy combined in subjects with advanced HCC: A phase II study (PEMRAD).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Stereotactic radiotherapy; Oncology; Hepatocellular carcinoma; Radiosurgery; Radiation therapy; Internal medicine; Nuclear medicine; Radiology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002146919,0.0014433,0.002216656,0.0005086801,0.0003783186,0.000774912,0.0006634504,0.001154413,0.004086697],"category_scores_gemma":[0.0006815597,0.0007242268,0.001176767,0.0004715637,0.0006496598,0.0006176649,0.0004688663,0.002030402,0.00128644],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006548832,"about_ca_system_score_gemma":0.001104036,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007420265,"about_ca_topic_score_gemma":0.001141736,"domain_scores_codex":[0.9994715,0.0002752637,0.00002745442,0.00008294067,0.00004903211,0.00009381556],"domain_scores_gemma":[0.9994293,0.00008028495,0.0001002218,0.0000536037,0.00003299994,0.0003036442],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7707577,0.09691361,0.01238977,0.001073884,0.002797101,0.0003386926,0.0002374066,0.0009309514,0.02321209,0.0001735588,0.002651704,0.08852353],"study_design_scores_gemma":[0.5907738,0.382508,0.02058456,0.00003511151,0.0007925154,0.0003320406,0.0000472028,0.0005202221,0.001582914,0.00008334957,0.002720484,0.00001979399],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895785,0.004891837,0.0004275457,0.0003266909,0.0001067122,0.00246344,0.0007246527,0.00006747206,0.001413001],"genre_scores_gemma":[0.9867797,0.003017581,0.00136658,0.0008040227,0.0003273983,0.002939893,0.002149982,0.00002384311,0.002591165],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004086697,"threshold_uncertainty_score":0.0136714,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05170645995102063,"score_gpt":0.4667635553039907,"score_spread":0.41505709535297,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}